ResMed (RMD) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $195.78 -1.61%
Revenue Growth %: +13.1%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
DIT, AMC, DPZ, More
Revenue Growth %: +13.1%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.43, $0.11 better than the analyst estimate of $2.32. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.27 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Reiterates Buy Rating on Tractor Supply Company (TSCO) Amid Soft Q2 Expectations
- Brookfield Renewable Energy (BEP) PT Raised to $41 at CIBC
- CMS Energy (CMS) PT Raised to $86 at BMO Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
